RT Journal Article
SR Electronic
T1 Associations Between Female Sex Hormones and Skeletal Muscle Ageing: The Baltimore Longitudinal Study of Ageing
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.10.06.24314971
DO 10.1101/2024.10.06.24314971
A1 Critchlow, Annabel J.
A1 Alexander, Sarah E.
A1 Hiam, Danielle
A1 Ferrucci, Luigi
A1 Scott, David
A1 Lamon, Séverine
YR 2024
UL http://medrxiv.org/content/early/2024/10/07/2024.10.06.24314971.abstract
AB Background To date, most research investigating the influence of circulating sex hormones on ageing female skeletal muscle has been cross-sectional and focused only on dichotomised young and old, or pre- versus post-menopausal groups. This excludes an important transitional period from high to low circulating oestrogen. Using secondary data from the Baltimore Longitudinal Study of Aging, this study aimed to investigate cross-sectional and longitudinal associations between circulating sex hormones and skeletal muscle mass and function across a continuum of ages.Methods Multiple and binomial linear regression was used to map cross-sectional (n=319) and longitudinal (n=83) associations between circulating sex hormones (oestradiol (E2), free oestradiol index (FEI), free (TT) and bioavailable testosterone (BioT), testosterone/oestradiol ratio (T/E2)) and skeletal muscle mass and function in healthy females. Cross-sectional models analysed females across an ageing continuum (24-89 years) and longitudinal associations were tested across 4-6 years of ageing in females over 50 years old. Models were adjusted for age, height, physical activity, comorbidities, and ethnicity.Results Cross-sectionally, serum E2 and FEI were positively associated with relative appendicular lean mass (ALM; β=0.28 and 0.20, respectively, p<0.05) and thigh muscle percentage (β=0.19 and 0.15, respectively, p<0.05). E2 and FEI were negatively associated with total body fat percentage (β=-0.30 and -0.21, respectively, p<0.05). BioT was positively associated with absolute ALM (β=0.13, p<0.05) and total body fat percentage (β=0.18, p<0.05). TT was negatively associated with total body fat percentage (β=-0.14, p<0.05). The T/E2 ratio was negatively associated with thigh muscle CSA (β=-0.08, p<0.05) and hamstring strength (β=-0.12, p<0.05). Across 4-6 years, ΔE2 and ΔFEI were positively associated with the change in ALM (β=0.29 and 0.42, respectively, p<0.05), and ΔFEI was positively associated with the change in handgrip strength (β=0.17, p<0.05). ΔTT and ΔBioT were negatively associated with the change in relative ALM (β=-0.25 for both, p<0.05) and relative quadriceps strength (β=-0.12 and -0.27, respectively, p<0.05)Conclusion This study demonstrates novel associations between sex hormone levels and skeletal muscle in females across a wide continuum of ages. We also demonstrate that longitudinal fluctuations in circulating sex hormones must be considered to gain a comprehensive understanding of female muscle ageing.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by Australian Research Council Future Fellowship (FT210100278) and National Health and Medical Research Council (NHMRC) Australia Investigator Grant (GNT1174886).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Deakin University Human Research Ethics Committee of Deakin University waived ethical approval for this work (project number: 2023-029) on 07/02/2023I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript. https://www.blsa.nih.gov/blsa-data-use